Primary myocardial fibrosis: a distinct entity characterized by heterogeneous histology

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Primary myocardial fibrosis : a distinct entity characterized by heterogeneous histology. / Pakanen, Lasse; Appel, Henrik; Ahtikoski, Anne; Holm, Pernille Heimdal; Kreus, Mervi; Olsen, Kristine Boisen; Banner, Jytte; Winkel, Bo Gregers; Huikuri, Heikki; Kaarteenaho, Riitta; Junttila, Juhani.

I: Cardiovascular Pathology, Bind 67, 107573, 2023.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Pakanen, L, Appel, H, Ahtikoski, A, Holm, PH, Kreus, M, Olsen, KB, Banner, J, Winkel, BG, Huikuri, H, Kaarteenaho, R & Junttila, J 2023, 'Primary myocardial fibrosis: a distinct entity characterized by heterogeneous histology', Cardiovascular Pathology, bind 67, 107573. https://doi.org/10.1016/j.carpath.2023.107573

APA

Pakanen, L., Appel, H., Ahtikoski, A., Holm, P. H., Kreus, M., Olsen, K. B., Banner, J., Winkel, B. G., Huikuri, H., Kaarteenaho, R., & Junttila, J. (2023). Primary myocardial fibrosis: a distinct entity characterized by heterogeneous histology. Cardiovascular Pathology, 67, [107573]. https://doi.org/10.1016/j.carpath.2023.107573

Vancouver

Pakanen L, Appel H, Ahtikoski A, Holm PH, Kreus M, Olsen KB o.a. Primary myocardial fibrosis: a distinct entity characterized by heterogeneous histology. Cardiovascular Pathology. 2023;67. 107573. https://doi.org/10.1016/j.carpath.2023.107573

Author

Pakanen, Lasse ; Appel, Henrik ; Ahtikoski, Anne ; Holm, Pernille Heimdal ; Kreus, Mervi ; Olsen, Kristine Boisen ; Banner, Jytte ; Winkel, Bo Gregers ; Huikuri, Heikki ; Kaarteenaho, Riitta ; Junttila, Juhani. / Primary myocardial fibrosis : a distinct entity characterized by heterogeneous histology. I: Cardiovascular Pathology. 2023 ; Bind 67.

Bibtex

@article{0ded66c363db455b81f27a5731f2a147,
title = "Primary myocardial fibrosis: a distinct entity characterized by heterogeneous histology",
abstract = "Primary myocardial fibrosis (PMF), defined as myocardial fibrosis in the absence of identifiable causes, may represent a common alternative phenotype in various cardiomyopathies and contribute to sudden cardiac death (SCD). No previous definitions of histopathological characteristics exist for PMF. We aimed to evaluate whether common features of fibrosis could be identified. PMF cases (n = 28) were selected from the FinGesture cohort consisting of 5,869 SCD victims that underwent a medicolegal autopsy. Twelve trauma controls and 10 ischemic heart disease cases were selected as reference groups. Further 3 PMF cases and 5 ischemic heart disease cases from autopsies performed in the University of Copenhagen, Denmark, were selected for a validation substudy. Relative area of fibrosis, amount of diffuse and perivascular fibrosis, and location of fibrosis were assessed from left ventricle myocardial samples stained with Masson trichrome. Further evaluations were performed with alpha-smooth muscle actin (α-SMA), vimentin, and CD68 stainings. Mean relative area of fibrosis was 5.8 ± 10.7%, 1.0 ± 0.7%, and 7.0 ± 7.4% in PMF, trauma controls, and ischemic cases, respectively. Fibrosis in the PMF group was mostly located in other sites than the endocardium. Most cases with fibrosis had vimentin-positive but α-SMA-negative stromal cells within fibrotic areas. Histopathologically, PMF represents a heterogeneous entity with variable fibrotic lesions affecting the whole myocardium and a suggested significant role of fibroblasts. These findings may bring validation to PMF being a common manifestation of cardiomyopathies. Evidently, PMF stands out as a particular entity demanding special attention as a cause of SCD.",
keywords = "Faculty of Health and Medical Sciences",
author = "Lasse Pakanen and Henrik Appel and Anne Ahtikoski and Holm, {Pernille Heimdal} and Mervi Kreus and Olsen, {Kristine Boisen} and Jytte Banner and Winkel, {Bo Gregers} and Heikki Huikuri and Riitta Kaarteenaho and Juhani Junttila",
year = "2023",
doi = "10.1016/j.carpath.2023.107573",
language = "English",
volume = "67",
journal = "Cardiovascular Pathology",
issn = "1054-8807",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Primary myocardial fibrosis

T2 - a distinct entity characterized by heterogeneous histology

AU - Pakanen, Lasse

AU - Appel, Henrik

AU - Ahtikoski, Anne

AU - Holm, Pernille Heimdal

AU - Kreus, Mervi

AU - Olsen, Kristine Boisen

AU - Banner, Jytte

AU - Winkel, Bo Gregers

AU - Huikuri, Heikki

AU - Kaarteenaho, Riitta

AU - Junttila, Juhani

PY - 2023

Y1 - 2023

N2 - Primary myocardial fibrosis (PMF), defined as myocardial fibrosis in the absence of identifiable causes, may represent a common alternative phenotype in various cardiomyopathies and contribute to sudden cardiac death (SCD). No previous definitions of histopathological characteristics exist for PMF. We aimed to evaluate whether common features of fibrosis could be identified. PMF cases (n = 28) were selected from the FinGesture cohort consisting of 5,869 SCD victims that underwent a medicolegal autopsy. Twelve trauma controls and 10 ischemic heart disease cases were selected as reference groups. Further 3 PMF cases and 5 ischemic heart disease cases from autopsies performed in the University of Copenhagen, Denmark, were selected for a validation substudy. Relative area of fibrosis, amount of diffuse and perivascular fibrosis, and location of fibrosis were assessed from left ventricle myocardial samples stained with Masson trichrome. Further evaluations were performed with alpha-smooth muscle actin (α-SMA), vimentin, and CD68 stainings. Mean relative area of fibrosis was 5.8 ± 10.7%, 1.0 ± 0.7%, and 7.0 ± 7.4% in PMF, trauma controls, and ischemic cases, respectively. Fibrosis in the PMF group was mostly located in other sites than the endocardium. Most cases with fibrosis had vimentin-positive but α-SMA-negative stromal cells within fibrotic areas. Histopathologically, PMF represents a heterogeneous entity with variable fibrotic lesions affecting the whole myocardium and a suggested significant role of fibroblasts. These findings may bring validation to PMF being a common manifestation of cardiomyopathies. Evidently, PMF stands out as a particular entity demanding special attention as a cause of SCD.

AB - Primary myocardial fibrosis (PMF), defined as myocardial fibrosis in the absence of identifiable causes, may represent a common alternative phenotype in various cardiomyopathies and contribute to sudden cardiac death (SCD). No previous definitions of histopathological characteristics exist for PMF. We aimed to evaluate whether common features of fibrosis could be identified. PMF cases (n = 28) were selected from the FinGesture cohort consisting of 5,869 SCD victims that underwent a medicolegal autopsy. Twelve trauma controls and 10 ischemic heart disease cases were selected as reference groups. Further 3 PMF cases and 5 ischemic heart disease cases from autopsies performed in the University of Copenhagen, Denmark, were selected for a validation substudy. Relative area of fibrosis, amount of diffuse and perivascular fibrosis, and location of fibrosis were assessed from left ventricle myocardial samples stained with Masson trichrome. Further evaluations were performed with alpha-smooth muscle actin (α-SMA), vimentin, and CD68 stainings. Mean relative area of fibrosis was 5.8 ± 10.7%, 1.0 ± 0.7%, and 7.0 ± 7.4% in PMF, trauma controls, and ischemic cases, respectively. Fibrosis in the PMF group was mostly located in other sites than the endocardium. Most cases with fibrosis had vimentin-positive but α-SMA-negative stromal cells within fibrotic areas. Histopathologically, PMF represents a heterogeneous entity with variable fibrotic lesions affecting the whole myocardium and a suggested significant role of fibroblasts. These findings may bring validation to PMF being a common manifestation of cardiomyopathies. Evidently, PMF stands out as a particular entity demanding special attention as a cause of SCD.

KW - Faculty of Health and Medical Sciences

U2 - 10.1016/j.carpath.2023.107573

DO - 10.1016/j.carpath.2023.107573

M3 - Journal article

C2 - 37683738

VL - 67

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

SN - 1054-8807

M1 - 107573

ER -

ID: 367898264